|
VARIATION IN WORLDWIDE TESTICULAR CANCER MORTALITY (p 1853)
June 06, 2001Death rates from testicular cancer remain inconsistent worldwide, with the overall trend in decreasing mortality being slower in eastern Europe compared with western Europe, USA, and Japan, conclude authors of a research letter in this week's issue of THE LANCET.
Testicular cancer is curable if treated appropriately. Fabio Levi and colleagues from the Cancer Epidemiology Unit, Lausanne, Switzerland, assessed trends of mortality from testicular cancer in Europe, the USA, and Japan. Information on death from testicular cancer was obtained from national mortality data recorded on the WHO Database.
In the European Union and the six countries of central and eastern Europe, peak mortality rates (1.6/100 000 and 1.7/100 000, respectively) were reached in the 1970's for the 20-44 age-group. In western Europe, the mortality rate has subsequently decreased by two-thirds; however, the decline in mortality has been slower - 22% - in eastern Europe. In the USA, the decrease in testicular cancer mortality has been around 70% after a peak (1.5/100000) in the late 1960s; Japan has consistently had a low mortality rate from testicular cancer , peaking at around 0.3/100000 in the late 1970s.
Fabio Levi comments: "Our findings suggest that, although platinum-based chemotherapy schemes have been available since the 1970s, the fall in testicular cancer mortality has not been consistent worldwide. The improvement in mortality has been earlier and greater in the USA than in the EU. These results support observations made for childhood cancers-when disease control depends on technological advances in medical care, North America benefits from earlier and more effective introduction of new therapeutic approaches than elsewhere. Education of both the public and health professionals, with respect to investigation of testicular abnormalities, might also be important".
Contact: Dr Fabio Levi, Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchatel, Institut Universitaire de Medecine Sociale et Preventive, CHU Falaises 1, 1011 Lausanne. Switzerland; T) 0041 21 314 72 40/0041 21 314 73 11; F) 0041 21 323 0303; E) fabio.levi@inst.hospvd.ch
Lancet
Cancer News and Current Cancer Events RSSCrossed (Evolutionary) Signals?
What do humans and single-celled choanoflagellates have in common? More than you'd think. New research into the choanoflagellate genome shows these ancient organisms have similar levels of proteins that cells in more complex organisms, including humans, use to communicate with each other.
New oral angiogenesis inhibitor offers potential nontoxic therapy for a wide range of cancers
The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results in mice, report researchers from Children's Hospital Boston.
'Hibernation-on-demand' drug significantly improves survival after extreme blood loss
For the first time, researchers have demonstrated that the administration of minute amounts of inhaled or intravenous hydrogen sulfide, or H2S - the molecule that gives rotten eggs their sulfurous stench - significantly improves survival from extreme blood loss in rats.
Effects of Healing Touch Therapy Being Studied
Often, a gentle hand on your shoulder when you're upset is all it takes to ease your mind and calm your nerves.
New paper offers insights into 'blinking' phenomena
A new paper by a team of researchers led by University of Notre Dame physicist Bolizsár Jankó provides an overview of research into one of the few remaining unsolved problems of quantum mechanics.
Sunburn alert: UVB does more damage to DNA than UVA
As bombs burst in air this July 4, chances are that sunburn will be the red glare that most folks see - and feel. But unfortunately, even when there is no burn, the effects of the sun's ultraviolet (UV) rays can have deadly consequences.
Happiness is rising around the world: U-M study
People in most countries around the world are happier these days, according to newly released data from the World Values Survey based at the University of Michigan Institute for Social Research.
Zinc finger proteins put personalized HIV therapy within reach
Researchers at the University of Pennsylvania School of Medicine and collaborators are using minute, naturally occurring proteins called zinc fingers to engineer T cells to one day treat AIDS in humans.
Plants in the fourth dimension
As anyone who has suffered from jetlag knows, we have internal clocks that tell us when to sleep and wake, and we can be miserable when these are disrupted.
Spiritual effects of hallucinogens persist, Johns Hopkins researchers report
In a follow-up to research showing that psilocybin, a substance contained in "sacred mushrooms," produces substantial spiritual effects, a Johns Hopkins team reports that those beneficial effects appear to last more than a year.
More Cancer News Articles
 | The Last Lecture by Randy Pausch, Jeffrey Zaslow |
 | The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health by T. Colin Campbell, Thomas M. Campbell II |
 | My Sister's Keeper: A Novel by Jodi Picoult |
 | Eat to Live: The Revolutionary Formula for Fast and Sustained Weight Loss by Joel Fuhrman |
 | Six Innings by James Preller |
 | Silent Spring by Rachel Carson |
 | Crazy Sexy Cancer Tips by Kris Carr |
 | Good Calories, Bad Calories by Gary Taubes |
 | Apples and Oranges: My Brother and Me, Lost and Found by Marie Brenner |
 | It's Not About the Bike: My Journey Back to Life by Lance Armstrong, Sally Jenkins |
| © 2008 BrightSurf.com |